The testing solution provides standardised, stable analytical data for scientific research and drug development.
Utilising advanced mass spectrometry and chromatography platforms, MtoZ Biolabs has developed a high-precision peptide purity testing solution to provide standardised, stable analytical data for scientific research and drug development.
What is peptide purity analysis?
Peptide purity testing involves applying analytical techniques, such as high-performance liquid chromatography (HPLC) and liquid chromatography-tandem mass spectrometry (LC-MS), to quantitatively assess the purity of a synthetic peptide sample and detect any impurities. This process addresses that proportion of the target peptide within the sample and elucidates the potential composition of impurities, generating a more accurate characterisation of overall sample quality.
Peptide purity analysis aims to:
- Verify if the main peak proportion of the target peptide meets the intended specifications
- Identify and qualitatively characterise the impurities
- Provide an analytical foundation for subsequent functional validation and downstream applications
High-precision purity analysis provides more accurate parameters for scientific studies, as well as fulfilling regulatory compliance requirements in pharmaceutical quality control.
Techniques and principles
Reverse-phase high-performance liquid chromatography (RP-HPLC) is a widely used method for analysing peptide purity. It separates peptides based on hydrophobic interactions and detects ultraviolet absorption at 214nm or 220nm. Purity is determined by calculating the area of the main peak relative to the total peak area, offering high separation efficiency and sensitivity to structural variations.
Liquid chromatography-mass spectrometry (LC-MS) combines the separation capabilities of liquid chromatography with mass spectrometry, allowing for both purity quantification and structural identification of impurities.
In pharmaceutical-grade peptide testing, two-dimensional liquid chromatography-mass spectrometry (2D-LC-MS) is increasingly adopted for its high-resolution separation and ability to detect trace-level impurities, making it ideal for stringent purity standards.
Levels and applications
Peptide purity is commonly categorised into 70%, 85%, 95%, and ≥98%, each with suitable for various research or development stages:
- 70% for early-stage exploratory studies and preliminary methodological investigations
- 85% for general functional validation and selected biochemical assays
- 95% is applied in structural-functional studies, protein–protein interaction analyses, and other experiments necessitating high-purity materials
- ≥98% used predominantly in preclinical investigations and pivotal phases of drug development
In the initial stages of research, investigators often prioritise cost and turnaround time, which may lead them to use lower-purity peptides. However, high-purity peptides are essential in advanced research and pharmaceutical development for ensuring reliable and reproducible data.
Low peptide purity can lead to signal interference, data bias, and failures in functional assays, potentially resulting in delays and challenges in achieving regulatory compliance. Therefore, choosing the correct purity specification is crucial for effective experimental design.
Interpreting results and common misconceptions
The purity value from HPLC is based on the peak area ratio of UV-absorbing components in the sample. Non-UV-absorbing substances, like water and salts, are excluded, meaning the reported purity does not reflect the actual mass percentage of the peptide.
Measuring at 214 nm enhances sensitivity to peptide bond absorption, providing a better signal-to-noise ratio, while 220 nm helps minimise background noise. The optimal wavelength should match the sample's properties and analytical needs for accurate detection.
In peptide purity reports, it is essential to consider the main chromatographic peak, the distribution of impurity peaks, and chromatographic resolution. These aspects indicate how easily impurities can be separated and highlight any co-elution events, guiding purification strategies.
MtoZ Biolabs Peptide Purity Testing Workflow
HPLC (High-Performance Liquid Chromatography) is a key tool in peptidomics research for peptide analysis and purity testing. The typical workflow includes:
- Sample preparation: Peptide samples are dissolved in solvents like water, acetonitrile, or methanol, and filtered to remove impurities, ensuring a stable test solution
- Column selection: The appropriate chromatographic column and stationary phase are chosen based on the sample's characteristics. The mobile phase composition, flow rate, gradient elution, and detection wavelength (commonly 214nm or 220nm) are optimized for effective separation
- System equilibration: The mobile phase is passed through the column until a stable baseline is achieved, preparing the system for analysis
- Sample injection: The test solution is introduced into the system accurately to avoid overloading
- Separation process: Sample components move through the column, separated by their interaction with the stationary phase under controlled temperature and pressure conditions
- Data capture: Detector responses are recorded to create a chromatogram, which shows retention times and signal intensities for purity assessment
- Data analysis: Analytical software calculates the main peak area ratio and peptide purity, while also analyzing impurity peaks for a comprehensive quality evaluation
MtoZ Biolabs also offers LC-MS or 2D-LC-MS methods for higher resolution and detailed impurity profiling, ensuring our peptide purity analysis meets both research and regulatory standards seamlessly.
